Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Jun-24 4:58 PM View:  | Abdun-Nabi Daniel Director | Aptevo Therapeutics Inc. (APVO) | 02-Jun-24 | Option Exercise | 81 | -- | -- | 41% 0.2K to 0.28K | |
| 03-Jun-24 4:42 PM View: | Grant Grady III Director | Aptevo Therapeutics Inc. (APVO) | 02-Jun-24 | Option Exercise | 81 | -- | -- | 69% 0.12K to 0.2K | |
| 03-Jun-24 4:58 PM View: | Kunz Barbara Lopez Director | Aptevo Therapeutics Inc. (APVO) | 02-Jun-24 | Option Exercise | 81 | -- | -- | 69% 0.12K to 0.2K | |
| 03-Jun-24 4:58 PM View: | Niederhuber John Director | Aptevo Therapeutics Inc. (APVO) | 02-Jun-24 | Option Exercise | 81 | -- | -- | 60% 0.14K to 0.22K | |
| 03-Jun-24 4:58 PM View: | Harsanyi Zsolt Director | Aptevo Therapeutics Inc. (APVO) | 02-Jun-24 | Option Exercise | 81 | -- | -- | 41% 0.2K to 0.28K | |
| 03-Jun-24 4:58 PM View: | Harsanyi Zsolt Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-24 | Option Exercise | 7 | -- | -- | 4% 0.19K to 0.2K | |
| 03-Jun-24 4:58 PM View: | Abdun-Nabi Daniel Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-24 | Option Exercise | 7 | -- | -- | 4% 0.19K to 0.2K | |
| 03-Jun-24 4:42 PM View: | Grant Grady III Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-24 | Option Exercise | 7 | -- | -- | 6% 0.11K to 0.12K | |
| 03-Jun-24 4:58 PM View: | Kunz Barbara Lopez Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-24 | Option Exercise | 7 | -- | -- | 6% 0.11K to 0.12K | |
| 03-Jun-24 4:58 PM View: | Niederhuber John Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-24 | Option Exercise | 7 | -- | -- | 5% 0.13K to 0.14K | |
| 03-Jun-24 4:31 PM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 31-May-24 | Option Exercise | 42 | -- | -- | 8% 0.55K to 0.59K | |
| 05-Mar-24 4:13 PM View: | Taylor Daphne L SVP, CFO | Aptevo Therapeutics Inc. (APVO) | 04-Mar-24 | Option Exercise | 1,584 | -- | -- | 9% 16.83K to 18.41K | |
| 05-Mar-24 4:12 PM View: | Lamothe Jeffrey G. EVP, COO | Aptevo Therapeutics Inc. (APVO) | 03-Mar-24 | Option Exercise | 3,667 | -- | -- | 11% 33.84K to 37.5K | |
| 05-Mar-24 4:06 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 03-Mar-24 | Option Exercise | 9,584 | -- | -- | 17% 57.85K to 67.43K | |
| 05-Mar-24 4:07 PM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 03-Mar-24 | Option Exercise | 3,667 | -- | -- | 18% 20.38K to 24.04K | |
| 05-Mar-24 4:13 PM View: | Taylor Daphne L SVP, CFO | Aptevo Therapeutics Inc. (APVO) | 02-Mar-24 | Option Exercise | 3,667 | -- | -- | 28% 13.16K to 16.83K | |
| 05-Mar-24 4:07 PM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 02-Mar-24 | Option Exercise | 3,667 | -- | -- | 22% 16.71K to 20.38K | |
| 05-Mar-24 4:12 PM View: | Lamothe Jeffrey G. EVP, COO | Aptevo Therapeutics Inc. (APVO) | 02-Mar-24 | Option Exercise | 5,500 | -- | -- | 19% 28.34K to 33.84K | |
| 05-Mar-24 4:06 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 02-Mar-24 | Option Exercise | 12,917 | -- | -- | 29% 44.93K to 57.85K | |
| 30-Jan-24 6:05 PM View: | Taylor Daphne L SVP, CFO | Aptevo Therapeutics Inc. (APVO) | 29-Jan-24 | Option Exercise | 792 | -- | -- | 6% 12.37K to 13.16K | |
| 30-Jan-24 6:04 PM View: | Lamothe Jeffrey G. EVP, COO | Aptevo Therapeutics Inc. (APVO) | 28-Jan-24 | Option Exercise | 1,833 | -- | -- | 7% 26.5K to 28.34K | |
| 30-Jan-24 6:02 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 28-Jan-24 | Option Exercise | 4,792 | -- | -- | 12% 40.14K to 44.93K | |
| 10-Aug-23 4:08 PM View: | Harsanyi Zsolt Director | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 73% 4.9K to 8.47K | |
| 10-Aug-23 4:05 PM View: | Abdun-Nabi Daniel Director | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 75% 4.77K to 8.34K | |
| 10-Aug-23 4:07 PM View: | Grant Grady III Director | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 273% 1.31K to 4.88K | |
| 10-Aug-23 4:10 PM View: | Kunz Barbara Lopez Director | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 273% 1.31K to 4.88K | |
| 10-Aug-23 4:12 PM View: | Niederhuber John Director | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 169% 2.11K to 5.68K | |
| 10-Aug-23 8:44 AM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 08-Aug-23 | Option Exercise | 9,375 | -- | -- | 128% 7.33K to 16.71K | |
| 10-Aug-23 8:47 AM View: | Taylor Daphne L SVP, CFO | Aptevo Therapeutics Inc. (APVO) | 08-Aug-23 | Option Exercise | 6,945 | -- | -- | 128% 5.42K to 12.37K | |
| 10-Aug-23 8:41 AM View: | Lamothe Jeffrey G. EVP, COO | Aptevo Therapeutics Inc. (APVO) | 08-Aug-23 | Option Exercise | 13,812 | -- | -- | 109% 12.69K to 26.5K | |
| 02-Jun-23 4:43 PM View: | Abdun-Nabi Daniel Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 7% 4.47K to 4.77K | |
| 02-Jun-23 4:48 PM View: | Grant Grady III Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 29% 1.01K to 1.31K | |
| 02-Jun-23 4:46 PM View: | Kunz Barbara Lopez Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 29% 1.01K to 1.31K | |
| 02-Jun-23 4:44 PM View: | Niederhuber John Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 16% 1.81K to 2.11K | |
| 02-Jun-23 4:41 PM View: | Harsanyi Zsolt Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 6% 4.61K to 4.9K | |
| 02-Jun-23 4:39 PM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 31-May-23 | Option Exercise | 1,834 | -- | -- | 33% 5.5K to 7.33K | |
| 07-Mar-23 10:00 PM View: | Taylor Daphne L SVP, CFO | Aptevo Therapeutics Inc. (APVO) | 04-Mar-23 | Option Exercise | 1,583 | -- | -- | 41% 3.84K to 5.42K | |
| 07-Mar-23 4:37 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 03-Mar-23 | Option Exercise | 9,582 | -- | -- | 31% 30.55K to 40.14K | |
| 07-Mar-23 4:42 PM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 03-Mar-23 | Option Exercise | 3,666 | -- | -- | 200% 1.83K to 5.5K | |
| 07-Mar-23 4:44 PM View: | Lamothe Jeffrey G. EVP, COO | Aptevo Therapeutics Inc. (APVO) | 03-Mar-23 | Option Exercise | 3,666 | -- | -- | 41% 9.03K to 12.69K | |
| 30-Jan-23 1:07 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 29-Jan-23 | Option Exercise | 4,791 | -- | -- | 19% 25.76K to 30.55K | |
| 30-Jan-23 1:04 PM View: | Lamothe Jeffrey G. CFO | Aptevo Therapeutics Inc. (APVO) | 29-Jan-23 | Option Exercise | 1,834 | -- | -- | 26% 7.19K to 9.03K | |
| 03-Jun-22 3:10 PM View: | Harsanyi Zsolt Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 7% 4.31K to 4.61K | |
| 03-Jun-22 3:13 PM View: | Kwon Soyoung SVP, GC and Corporate Affairs | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 1,833 | -- | -- | 100% 0 to 1.83K | |
| 03-Jun-22 3:16 PM View: | Abdun-Nabi Daniel Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 4% 7.81K to 8.11K | |
| 03-Jun-22 2:56 PM View: | Grant Grady III Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 42% 0.71K to 1.01K | |
| 03-Jun-22 3:01 PM View: | Kunz Barbara Lopez Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 42% 0.71K to 1.01K | |
| 03-Jun-22 3:06 PM View: | Niederhuber John Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 13% 2.32K to 2.62K | |
| 01-Feb-22 6:00 PM View: | Lamothe Jeffrey G. SVP and CFO | Aptevo Therapeutics Inc. (APVO) | 29-Jan-22 | Option Exercise | 1,833 | -- | -- | 34% 5.36K to 7.19K | |
| 01-Feb-22 6:01 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 29-Jan-22 | Option Exercise | 4,792 | -- | -- | 23% 20.97K to 25.76K |
